Galapagos expands its collaboration with Serono
21-Oct-2005
The unique combination of BioFocus' and Serono's capabilities have proven to be highly fruitful, and it is envisaged that this increased collaboration will lead to further drug discovery programs between the two companies.
Under the terms of the agreement, Galapagos will receive technology access fees for library compounds, plus a fee-for-service component for medicinal chemistry services.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.